122 related articles for article (PubMed ID: 18206358)
1. Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil.
Philip AK; Pathak K; Shakya P
Eur J Pharm Biopharm; 2008 Jun; 69(2):658-66. PubMed ID: 18206358
[TBL] [Abstract][Full Text] [Related]
2. Phase transited and vapor-induced dual capsular system (DCS) for achieving delayed and osmotic release of cefadroxil.
Philip AK; Philip B
Pharm Dev Technol; 2011 Oct; 16(5):457-65. PubMed ID: 20482448
[TBL] [Abstract][Full Text] [Related]
3. In Situ Phase-Transited Asymmetric Membrane Capsules: A Means for Achieving Delayed and Osmotic Release for pH Solubility-Dependant Drugs.
Philip AK; Philip B
PDA J Pharm Sci Technol; 2011; 65(1):32-41. PubMed ID: 21414938
[TBL] [Abstract][Full Text] [Related]
4. Phase Transited Asymmetric Membrane Capsule: A Means for Achieving Delayed and Controlled Osmotic Flow.
Philip AK; Philip B
Curr Drug Deliv; 2010 Jul; 7(3):230-7. PubMed ID: 20497101
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
[TBL] [Abstract][Full Text] [Related]
6. In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug.
Philip A; Pathak K
PDA J Pharm Sci Technol; 2007; 61(1):24-36. PubMed ID: 17390701
[TBL] [Abstract][Full Text] [Related]
7. Osmotically regulated flow of flurbiprofen through in situ formed asymmetric membrane capsule.
Philip AK
Curr Drug Deliv; 2008 Apr; 5(2):127-32. PubMed ID: 18393815
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
Choudhury PK; Ranawat MS; Pillai MK; Chauhan CS
Acta Pharm; 2007 Sep; 57(3):343-50. PubMed ID: 17878113
[TBL] [Abstract][Full Text] [Related]
9. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility.
Philip AK; Pathak K
AAPS PharmSciTech; 2006 Jul; 7(3):56. PubMed ID: 17025237
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
[TBL] [Abstract][Full Text] [Related]
11. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
12. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system.
Kumar A; Philip AK; Pathak K
Curr Drug Deliv; 2011 Sep; 8(5):474-82. PubMed ID: 21696358
[TBL] [Abstract][Full Text] [Related]
14. Osmotically controlled oral delivery of ciprofloxacin through asymmetric membrane capsules.
Suman M; Chauhan DK; Reddy N
Pharmazie; 2012 Aug; 67(8):687-94. PubMed ID: 22957433
[TBL] [Abstract][Full Text] [Related]
15. Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug.
Philip AK; Pathak K
Drug Dev Ind Pharm; 2008 Jul; 34(7):735-43. PubMed ID: 18608466
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of osmotically controlled oral drug delivery system of glipizide.
Verma RK; Garg S
Eur J Pharm Biopharm; 2004 May; 57(3):513-25. PubMed ID: 15093601
[TBL] [Abstract][Full Text] [Related]
17. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs.
Prabakaran D; Singh P; Jaganathan KS; Vyas SP
J Control Release; 2004 Mar; 95(2):239-48. PubMed ID: 14980772
[TBL] [Abstract][Full Text] [Related]
18. Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.
Chauhan MS; Kumar A; Pathak K
AAPS PharmSciTech; 2012 Dec; 13(4):1492-501. PubMed ID: 23104305
[TBL] [Abstract][Full Text] [Related]
19. In situ formed phase transited drug delivery system of ketoprofen for achieving osmotic, controlled and level a in vitro in vivo correlation.
Philip AK; Pathak K
Indian J Pharm Sci; 2008 Nov; 70(6):745-53. PubMed ID: 21369435
[TBL] [Abstract][Full Text] [Related]
20. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet.
Rahim N; Naqvi SB; Bibi R; Iffat W; Shakeel S; Muhammad IN
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1467-75. PubMed ID: 25176230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
